Immutep Enters Second Collaboration With MSD For A New Randomised Phase IIB Trial In Head And Neck Cancer
New Phase IIb trial called TACTI-003, to evaluate eftilagimod alpha in combination with MSD’s KEYTRUDA® (pembrolizumab) in 1st line head...
New Phase IIb trial called TACTI-003, to evaluate eftilagimod alpha in combination with MSD’s KEYTRUDA® (pembrolizumab) in 1st line head...
Accelerating Scale by Expanding Geographical Operating Footprint with New Location in Florida and New HampshireCINCINNATI, March 16, 2021 (GLOBE NEWSWIRE)...
SOUTH SAN FRANCISCO, Calif., March 16, 2021 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a cardio-metabolic biotechnology company developing transformational treatments...
-Post Hoc analysis published in The Journal of Emergency Medicine demonstrates patients with moderate to severe CABP can be managed...
Four abstracts accepted as poster presentations for the Endocrine Society’s Annual MeetingLYON, France and NEWTON, Mass., March 16, 2021 (GLOBE...
Topline Results Expected in the Second Quarter of 2021SAN DIEGO, March 16, 2021 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO)...
SOUTH SAN FRANCISCO, Calif., March 16, 2021 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biopharmaceutical company...
HORSHAM, Pa., March 16, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA”) (NASDAQ: SSKN), a medical technology company in...
SAN FRANCISCO, CA, March 16, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Oncology Pharma, Inc. (OTC: ONPH) revealed today the...
CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., March 16, 2021 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company...
Management to host conference call and webcast on March 23rd at 5:00 pm EDT / 2:00 pm PDTSAN DIEGO, March...
– Dose Escalation Portion of Phase 1 Trial of PRT543 Complete; Additional Expansion Cohorts Set to Initiate Early in the...
Programs receiving funding include those developing company’s proprietary cryopreserved NK and gamma delta T-cell candidatesSAN MATEO, Calif., March 16, 2021...
PITTSBURGH, March 16, 2021 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (NASDAQ: NBSE) (“NeuBase” or the “Company”), a biotechnology company accelerating...
Companies on the 2021 Inc. 5000 Regionals: Midwest list employed more than 43,000 peopleMINNEAPOLIS, March 16, 2021 (GLOBE NEWSWIRE) --...
ROCKVILLE, Md., March 16, 2021 (GLOBE NEWSWIRE) -- Innovative Cellular Therapeutics (ICT), a clinical stage biotechnology company developing a comprehensive...
SOUTH SAN FRANCISCO, Calif., March 16, 2021 (GLOBE NEWSWIRE) -- VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company committed to developing...
TORONTO, March 16, 2021 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) is...
SOUTH ORANGE, N.J., March 16, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology...
All proposals of the Board of Directors approvedChristoph Franz re-elected as Chairman of the Board of Directors; all current Board...